Discovery of 1,4-dihydroxy-2-naphthoate [corrected] prenyltransferase inhibitors: new drug leads for multidrug-resistant gram-positive pathogens
- PMID: 17658779
- PMCID: PMC2591091
- DOI: 10.1021/jm070638m
Discovery of 1,4-dihydroxy-2-naphthoate [corrected] prenyltransferase inhibitors: new drug leads for multidrug-resistant gram-positive pathogens
Erratum in
- J Med Chem. 2007 Oct 4;50(20):5048
Abstract
Since utilization of menaquinone in the electron transport system is a characteristic of Gram-positive organisms, the 1,4-dihydroxy-2-naphthoate prenyltransferase (MenA) inhibitors 1a and 2a act as selective antibacterial agents against organisms such as methicillin-resistant Stapylococcus aureus (MRSA), Staphylococcus epidermidis (MRSE), and Mycobacterium spp. Growth of drug-resistant Gram-positive organisms was sensitive to the MenA inhibitors, indicating that menaquinone synthesis is a valid new drug target in Gram-positive organisms.
Figures


References
-
- Gaynes R, Edwards JR. Overview of nosocomial infections caused by Gram-negative bacilli. Healthcare Epideol. 2005;41:848–854. - PubMed
- Francis JS, Doherty MC, Lopatin U, Johnston CP, Sinha G, Ross T, Cai M, Hanse NN, Per T, Ticehurst JR, Carroll K, Thomas DL, Nuermberger E, Bartlett JG. Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus. Clini. Infect. Dis. 2005;40:100–1007. - PubMed
- Schroeder MS. Clostridium difficile-associated diarrhea. Am. Fam. Physician. 2005;71:921. - PubMed
- Haddadin AS, Fappiano SA, Lipsett PA. Methicillin resistant Staphylococcus aureus (MRSA) in the intensive care unit. Postgrad. Med. J. 2002;78:385–392. - PMC - PubMed
- Richards MJ, Edwards JR, Culver DH, Gaynes RP. Nosocomial infections in medical intensive care units in the United States. Crit. Care Med. 1999;27:887–892. - PubMed
- Martin MA. Methicillin-resistant Staphylococcus aureus: the persistent resistant nosocomial pathogen. Curr. Clin. Top. Infect. Dis. 1994;14:170–191. - PubMed
-
- Cohen J. New TB drug promises shorter, simpler treatment. Science. 2004;306:1872. - PubMed
-
- Pagune DJ, Gwynn MN, Holmes DJ, Pompliano DL. Drugs for bad bugs: confronting the challenges of antibacterial discovery. Nat. Rev. 2007;6:29–40. - PubMed
-
-
The peptide sequences of the menA and ubiA gene products were only 21% identity and 35% similarity. See the following:Suvana KD, Stevenson R, Meganathan R, Hudspeth MES. Menaquinone (vitamin K2) biosynthesis: localization and characterization of the menA Gene from Escherichia coli. J. Bacteriol. 1998;180:2782–2787.
-
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous